Success Story: Approved in Just 19 Days! A Chemical Engineering Researcher Secures EB-1B Approval with Direct Premium Processing
Client’s Testimonial:
"Thank you very much for your help with this process. It is beyond great news that my petition was approved.”
On July 18th, 2026, we received EB-1B (Outstanding Professors and Researchers) approval for a Senior Research Scientist III in the Field of Chemical Engineering (Approval Notice).
General Field: Chemical Engineering
Position at the Time of Case Filing: Senior Research Scientist III
Country of Origin: Colombia
Approval Notice Date: July 18th, 2026
Processing Time: 19 days (Premium Processing Requested)
Case Summary:
We are pleased to share that the client’s I-140 EB-1B petition was approved in just 19 days after being filed directly with premium processing. The client, who holds both a Ph.D. and an M.S. in chemical engineering, specializes in developing data-driven and mechanistically informed approaches to pharmaceutical manufacturing. At the time of filing, the client was working as a senior research scientist, developing scalable crystallization and precipitation processes for active pharmaceutical ingredients while applying engineering and modeling tools to improve manufacturing reliability and product quality.
Advancing Pharmaceutical Manufacturing Through Chemical Engineering Research
The petition demonstrated that the client’s research addresses important challenges in pharmaceutical manufacturing by improving process reliability, scalability, and product consistency. The client’s work has focused on connecting manufacturing conditions with critical quality attributes of active pharmaceutical ingredients through predictive crystallization models and advanced engineering methodologies. We also highlighted the client’s contributions to computational modeling of crystallization processes and the development of advanced manufacturing strategies that support more reliable production of pharmaceutical compounds. In addition, the petition discussed the client’s pioneering research on solubility and nucleation kinetics in biodiesel crystallization systems, illustrating how foundational advances in crystallization science have informed applications extending into pharmaceutical manufacturing.
A Record of International Recognition
The client’s scholarly record included 13 peer-reviewed journal articles, including 6 first-authored publications, as well as 1 first-authored book chapter. At the time of filing, the client’s work had received 353 citations. Rather than presenting these numbers as automatically establishing eligibility, we demonstrated that the citation record reflected meaningful and independent reliance on the client’s research by scientists working across crystallization science, pharmaceutical manufacturing, process engineering, and related areas. The petition further emphasized that the client’s work had been published in highly selective journals, supporting the conclusion that the research had undergone rigorous scientific evaluation and had been recognized as valuable within the field.
Peer Review Demonstrates Professional Recognition
The petition also highlighted that the client had completed at least 5 peer reviews for respected scientific journals. Rather than treating peer-review service as a routine activity, we explained that journal editors typically invite reviewers only after recognizing their specialized expertise. Accordingly, this evidence demonstrated that other members of the scientific community trusted the client to evaluate the quality and validity of research submitted by fellow experts, further supporting the client’s standing within the field of chemical engineering.
Expert Endorsements
The petition was supported by 2 independent recommendation letters from internationally recognized experts who were familiar with the client’s research through its published influence rather than personal collaboration. These letters reinforced the objective evidence by explaining the originality and significance of the client’s contributions to crystallization science and pharmaceutical manufacturing.
EB-1B Approval in 19 Days
By presenting the client’s achievements as a cohesive record of original research contributions, independent scholarly recognition, trusted peer-review service, and sustained impact on pharmaceutical manufacturing and crystallization science, we demonstrated that the client satisfied the requirements for classification as an Outstanding Researcher under the EB-1B category. We congratulate the client on this I-140 EB-1B approval in just 19 days without any RFE issues and wish the client continued success in advancing chemical engineering research and pharmaceutical manufacturing in the United States.